Internal Medicine, Cardiovascular Disease · Southfield, MI
NPI
1861483646
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
27177 Lahser Rd, Ste 103
Southfield, MI, 48034
Phone (248) 357-2722
Groups this clinician bills Medicare through
Medicare paid, 2024
$224K
2,527 services
Medicare patients, 2024
348
Average age 75
Drug cost, 2024
$1.1M
4,969 prescriptions
Company payments, 2025
$1,181
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vijay S Kudesia was code 99454 (e&m - miscellaneous), 386 times for 46 patients. In total Vijay S Kudesia billed 2,527 services in 46 codes, and Medicare paid $224K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99454 E&M - Miscellaneous | Office | 386 | 46 | $39.22 | $15K |
| 99457 E&M - Miscellaneous | Office | 358 | 49 | $41.77 | $15K |
| 99214 Office E&M - Established | Office | 315 | 188 | $98.41 | $31K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 152 | 38 | $4.28 | $651 |
| 93306 Echocardiography (TTE/TEE) | Office | 132 | 131 | $149.22 | $20K |
| 93015 Electrocardiogram | Office | 126 | 94 | $51.66 | $6,509 |
| 99213 Office E&M - Established | Office | 114 | 86 | $62.44 | $7,118 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 98 | 49 | $98.07 | $9,610 |
| 93229 Electrocardiogram | Office | 90 | 90 | $673.58 | $61K |
| 93228 Electrocardiogram | Office | 90 | 90 | $21.20 | $1,908 |
| 93000 Electrocardiogram | Office | 86 | 79 | $11.15 | $959 |
| 93306 Echocardiography (TTE/TEE) | Facility | 55 | 54 | $57.70 | $3,173 |
| 99232 Hospital E&M - Subsequent | Facility | 54 | 16 | $68.18 | $3,682 |
| 99458 E&M - Miscellaneous | Office | 52 | 20 | $33.99 | $1,767 |
| 78452 Myocardial Perfusion Scan | Office | 49 | 49 | $362.15 | $18K |
By year: 2022 $215K for 2,779 services; 2023 $197K for 2,145 services; 2024 $224K for 2,527 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vijay S Kudesia prescribed most often to Medicare patients was Atorvastatin Calcium, with 383 prescriptions and refills. In total Vijay S Kudesia wrote 4,969 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 383 | 933 | 102 | $5,117 |
| Amlodipine Besylate Generic | 364 | 1,026 | 115 | $3,201 |
| Nifedipine Er Nifedipine | 339 | 841 | 84 | $17K |
| Metoprolol Succinate Generic | 297 | 796 | 87 | $4,729 |
| Eliquis Apixaban | 217 | 382 | 51 | $211K |
| Carvedilol Generic | 190 | 520 | 54 | $2,655 |
| Losartan Potassium Generic | 190 | 476 | 62 | $2,526 |
| Hydrochlorothiazide Generic | 182 | 444 | 51 | $1,101 |
| Rosuvastatin Calcium Generic | 177 | 481 | 54 | $3,546 |
| Lisinopril Generic | 165 | 399 | 49 | $1,926 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 158 | 371 | 43 | $2,642 |
| Clopidogrel Clopidogrel Bisulfate | 153 | 409 | 46 | $3,110 |
| Metoprolol Tartrate Generic | 151 | 395 | 40 | $1,572 |
| Ramipril Generic | 144 | 379 | 41 | $2,523 |
| Ezetimibe Generic | 124 | 305 | 40 | $2,582 |
Brand drugs: 785 claims; generic drugs: 4,184 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vijay S Kudesia $1,181 ($1,181 in general payments such as food, travel and fees) from 13 companies. The largest payer was Merck Sharp & Dohme LLC with $249.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 9 | $249 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $206 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $157 |
| Scpharmaceuticals Inc. SCPH | 7 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $102 |
| Alnylam Pharmaceuticals Inc. ALNY | 4 | $65.45 |
| Baxter Healthcare BAX | 1 | $63.97 |
| Novo Nordisk Inc NVO | 2 | $53.84 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $43.5 |
| Pfizer Inc. PFE | 1 | $38.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.